# Atorvastatin as an Antihypertensive Agent

> **NCT05679102** · NA · COMPLETED · sponsor: **Himayat Ullah** · enrollment: 120 (actual)

## Conditions studied

- Atorvastatin Antihypertensive Effect

## Interventions

- **DRUG:** Amlodipine 5 MG Oral Tablet
- **DRUG:** Amlodipine 5 MG / Atorvastatin 10 MG Oral Tablet

## Key facts

- **NCT ID:** NCT05679102
- **Lead sponsor:** Himayat Ullah
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-20
- **Primary completion:** 2023-01-04
- **Final completion:** 2023-01-04
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2023-01-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05679102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05679102, "Atorvastatin as an Antihypertensive Agent". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05679102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*